Logo

Get Healthy!

Results for search "Cancer: Lymphoma".

Health News Results - 16

TUESDAY, April 9, 2019 (HealthDay News) -- A new method of brewing a cancer vaccine inside a patient's tumor could harness the power of the immune system to destroy the disease, researchers report.

Immune stimulants are injected directly into a tumor, which teaches the immune system to recognize and destroy all similar cancer cells throughout the body, said senior researcher Dr...

THURSDAY, March 21, 2019 (HealthDay News) -- She's cute, and perhaps a medical breakthrough.

Scientists say they have used frozen testicular tissue to achieve the birth of a healthy baby monkey named Grady -- a success they hope to eventually translate to childhood cancer survivors whose treatment has left them infertile.

Infertility is a potential side effect of the chemoth...

MONDAY, Oct. 22, 2018 (HealthDay News) -- Paying extra for those pricey organic fruits and vegetables might pay off: New research suggests eating them might help you dodge a cancer diagnosis.

People who consumed the most organic foods had a 25 percent lower cancer risk compared with those who ate the least, the study found.

Specifically, eating more organically grown foods ...

TUESDAY, Sept. 4, 2018 (HealthDay News) -- Younger women who undergo chemotherapy for lung cancer are more likely to experience early menopause, researchers have found.

The new study included 182 women who were an average age of 43 when they were diagnosed with lung cancer.

Within a year, 64 percent of the 85 women who received systemic chemotherapy had entered menopause, co...

WEDNESDAY, Aug. 22, 2018 (HealthDay News) -- Poverty is a major reason black and Hispanic children with some types of cancer have lower survival rates than white patients, a new study finds.

Researchers examined U.S. government data on nearly 32,000 black, Hispanic and white children who were diagnosed with cancer between 2000 and 2011. For several cancers, whites were much more likel...

TUESDAY, Aug. 21, 2018 (HealthDay News) -- A blood test can predict which lymphoma patients will respond well to normal treatment and which may need a more aggressive approach, researchers report.

Their study included 217 patients with diffuse large B cell lymphoma, the most common type of the blood cancer non-Hodgkin lymphoma.

The blood test checks levels of circulating tum...

MONDAY, June 11, 2018 (HealthDay News) -- Long-term antiviral treatment cuts the risk of cancer in HIV patients as they age, a new study says.

People with HIV are at increased risk for both AIDS-related cancers (Kaposi sarcoma, non-Hodgkin lymphoma or invasive cervical cancer) and non-AIDS-related cancers (lung and larynx cancer, melanoma and leukemia).

Antiretroviral therap...

WEDNESDAY, Jan. 31, 2018 (HealthDay News) -- Could a cancer "vaccine" fight more than one kind of malignancy?

A new study in mice suggests it's possible: A shot containing two compounds that stimulate the immune system was injected directly into tumors and killed those cancer cells.

Not only that, it also destroyed rogue cells from the tumors that had already traveled to ot...

MONDAY, Jan. 22, 2018 (HealthDay News) -- A possible link between a cluster of cases in New York City of an extremely rare type of cancer and the 1986 Chernobyl nuclear plant disaster in Ukraine has been found by researchers.

They began their investigation after 10 people in New York City were diagnosed with vitreoretinal lymphoma (VRL) in a four-year span.

VRL affects the e...

TUESDAY, Dec. 12, 2017 (HealthDay News) -- Physical activity appears to help people with lymphoma survive their disease.

That finding comes from a new study by Mayo Clinic researchers of nearly 4,100 people with lymphoma, a cancer that starts in the white blood cells that normally help fight infection.

"As physicians, we recommend physical activity for all cancer survivors t...

FRIDAY, Oct. 20, 2017 (HealthDay News) -- A particular breast implant may be associated with a rare type of cancer, researchers report.

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is estimated to affect 1 in 30,000 women each year, but researchers said it may actually be more common.

"We're seeing that this cancer is likely very underreported, and as ...

WEDNESDAY, Oct. 4, 2017 (HealthDay News) -- A newer drug may beat the standard treatment when it comes to battling the blood cancer follicular lymphoma, a clinical trial suggests.

Follicular lymphoma is one type of non-Hodgkin lymphoma, a group of cancers that arise in white blood cells.

The new study found that a drug called obinutuzumab (Gazyva) typically kept the cancer u...

WEDNESDAY, Sept. 27, 2017 (HealthDay News) -- Long-term treatment with the drug rituximab (Rituxan) may extend the lives of some patients with a rare form of blood cancer, a new clinical trial finds.

The disease, known as mantle-cell lymphoma, is generally incurable. But various treatments can prolong people's lives. Some patients, for instance, are able to undergo chemotherapy to wip...

TUESDAY, June 6, 2017 (HealthDay News) -- Public-funded trials have significantly extended the lives of people diagnosed with cancer, according to new research.

SWOG, the clinical trials network funded by the U.S. National Cancer Institute (NCI), has involved more than 200,000 patient volunteers. These trials have led to approval of 14 new cancer drugs and more than 100 changes to ca...

WEDNESDAY, April 26, 2017 (HealthDay News) -- Children given an organ transplant have a substantially higher risk of developing cancer -- in some cases up to 200 times higher -- than the general population, a new study finds.

But the individual risk of any one child getting cancer still remains very small, the study authors stressed.

Overall, the U.S. National Cancer Institu...

WEDNESDAY, April 5, 2017 (HealthDay News) -- As HIV becomes a lifetime disease instead of a killer, researchers say these patients will likely start to mirror other Americans when it comes to the kinds of cancers they develop.

By 2030, the total number of cancers in HIV-positive people is expected to decline dramatically, as fewer patients develop tumors linked to a ravaged immune sys...